These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30417194)

  • 1. Reversal of tumor malignization and modulation of cell behaviors through genome editing mediated by a multi-functional nanovector.
    Liu BY; He XY; Zhuo RX; Cheng SX
    Nanoscale; 2018 Dec; 10(45):21209-21218. PubMed ID: 30417194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor targeted genome editing mediated by a multi-functional gene vector for regulating cell behaviors.
    Liu BY; He XY; Zhuo RX; Cheng SX
    J Control Release; 2018 Dec; 291():90-98. PubMed ID: 30339905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide and Aptamer Decorated Delivery System for Targeting Delivery of Cas9/sgRNA Plasmid To Mediate Antitumor Genome Editing.
    Liu BY; He XY; Xu C; Ren XH; Zhuo RX; Cheng SX
    ACS Appl Mater Interfaces; 2019 Jul; 11(27):23870-23879. PubMed ID: 31257851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aptamer/Peptide-Functionalized Genome-Editing System for Effective Immune Restoration through Reversal of PD-L1-Mediated Cancer Immunosuppression.
    He XY; Ren XH; Peng Y; Zhang JP; Ai SL; Liu BY; Xu C; Cheng SX
    Adv Mater; 2020 Apr; 32(17):e2000208. PubMed ID: 32147886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Dual-Targeting Delivery System for Effective Genome Editing and In Situ Detecting Related Protein Expression in Edited Cells.
    Liu BY; He XY; Xu C; Xu L; Ai SL; Cheng SX; Zhuo RX
    Biomacromolecules; 2018 Jul; 19(7):2957-2968. PubMed ID: 29617556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional Vector for Delivery of Genome Editing Plasmid Targeting β-Catenin to Remodulate Cancer Cell Properties.
    He XY; Liu BY; Peng Y; Zhuo RX; Cheng SX
    ACS Appl Mater Interfaces; 2019 Jan; 11(1):226-237. PubMed ID: 30540162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-delivery of Sorafenib and CRISPR/Cas9 Based on Targeted Core-Shell Hollow Mesoporous Organosilica Nanoparticles for Synergistic HCC Therapy.
    Zhang BC; Luo BY; Zou JJ; Wu PY; Jiang JL; Le JQ; Zhao RR; Chen L; Shao JW
    ACS Appl Mater Interfaces; 2020 Dec; 12(51):57362-57372. PubMed ID: 33301289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-Selective Messenger RNA Delivery and CRISPR/Cas9 Genome Editing by Modulating the Interface of Phenylboronic Acid-Derived Lipid Nanoparticles and Cellular Surface Sialic Acid.
    Tang Q; Liu J; Jiang Y; Zhang M; Mao L; Wang M
    ACS Appl Mater Interfaces; 2019 Dec; 11(50):46585-46590. PubMed ID: 31763806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response.
    Haapaniemi E; Botla S; Persson J; Schmierer B; Taipale J
    Nat Med; 2018 Jul; 24(7):927-930. PubMed ID: 29892067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamer-functionalized albumin-based nanoparticles for targeted drug delivery.
    Xu L; He XY; Liu BY; Xu C; Ai SL; Zhuo RX; Cheng SX
    Colloids Surf B Biointerfaces; 2018 Nov; 171():24-30. PubMed ID: 30005287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel dual-targeting delivery system for specific delivery of CRISPR/Cas9 using hyaluronic acid, chitosan and AS1411.
    Khademi Z; Ramezani M; Alibolandi M; Zirak MR; Salmasi Z; Abnous K; Taghdisi SM
    Carbohydr Polym; 2022 Sep; 292():119691. PubMed ID: 35725215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A targeting delivery system for effective genome editing in leukemia cells to reverse malignancy.
    Ren XH; Xu C; Li LL; Zuo Y; Han D; He XY; Cheng SX
    J Control Release; 2022 Mar; 343():645-656. PubMed ID: 35157940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9 Assisted Multiplex Genome Editing Technique in Escherichia coli.
    Feng X; Zhao D; Zhang X; Ding X; Bi C
    Biotechnol J; 2018 Sep; 13(9):e1700604. PubMed ID: 29790644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assembly of CRISPR ribonucleoproteins with biotinylated oligonucleotides via an RNA aptamer for precise gene editing.
    Carlson-Stevermer J; Abdeen AA; Kohlenberg L; Goedland M; Molugu K; Lou M; Saha K
    Nat Commun; 2017 Nov; 8(1):1711. PubMed ID: 29167458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-Assembled Plasmid Delivery System for PPM1D Knockout to Reverse Tumor Malignancy.
    Ren XH; He XY; Liu BY; Xu C; Cheng SX
    ACS Appl Bio Mater; 2020 Nov; 3(11):7831-7839. PubMed ID: 35019523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene editing of MPS I human fibroblasts by co-delivery of a CRISPR/Cas9 plasmid and a donor oligonucleotide using nanoemulsions as nonviral carriers.
    Schuh RS; de Carvalho TG; Giugliani R; Matte U; Baldo G; Teixeira HF
    Eur J Pharm Biopharm; 2018 Jan; 122():158-166. PubMed ID: 29122734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aptamer-Functionalized and Backbone Redox-Responsive Hyperbranched Polymer for Targeted Drug Delivery in Cancer Therapy.
    Zhuang Y; Deng H; Su Y; He L; Wang R; Tong G; He D; Zhu X
    Biomacromolecules; 2016 Jun; 17(6):2050-62. PubMed ID: 27113017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.
    Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y
    Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromatin accessibility and guide sequence secondary structure affect CRISPR-Cas9 gene editing efficiency.
    Jensen KT; Fløe L; Petersen TS; Huang J; Xu F; Bolund L; Luo Y; Lin L
    FEBS Lett; 2017 Jul; 591(13):1892-1901. PubMed ID: 28580607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temperature effect on CRISPR-Cas9 mediated genome editing.
    Xiang G; Zhang X; An C; Cheng C; Wang H
    J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.